MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Initiation of AT-HOME PD2, a Remote Observational Study of Parkinson’s Disease Clinical Trial Participants

    R. Schneider, A. Hoyt, R. Wilson, S. Mahes, C. Stevens, C. Tarolli, J. Adams, B. Valdovinos, K. Lizarraga, P. Auinger, S. Benvengo, M. Monje, E. Macklin, D. Weintraub, K. Biglan, A. Ascherio, A. Espay, C. Tanner, D. Novak, J. Beck, I. Shoulson, T. Simuni, S. Sieberts, E. Dorsey, M. Schwarzschild (Rochester, USA)

    Objective: To describe the design and initiation of a remote, long-term observational Parkinson’s disease (PD) study - Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease…
  • 2024 International Congress

    How many days are required to reliably estimate diverse digital mobility outcomes from various gait domains with a lower back sensor in people with Parkinson’s disease?

    E. Gazit, J. Garcia-Aymerich, J. Buekers, S. Del Din, A. Mueller, W. Maetzler, A. Yarnall, C. Schlenstedt, A. Nieuwboer, A. Mirelman, H. Gassner, D. Singleton, B. Vereijken, L. Rochester, JM. Hausdorff (Tel aviv, Israel)

    Objective: To determine the  number of days needed to obtain reliable, diverse digital mobility outcomes (DMOs) from daily activity recordings obtained using a lower back,…
  • 2024 International Congress

    Characterization of Muscle activity before and during Freezing of Gait Episodes

    E. Jafari, S. Pardoel, A. Alakhras, J. Kofman, E. Lemaire, J. Nantel (Ottawa, Canada)

    Objective: Objective: The study aims to characterize surface electromyography (EMG) activity in the distal and proximal leg muscles of 17 participants with Parkinson’s disease (PD)…
  • 2024 International Congress

    LRRK2 in Parkinson’s Disease: A per-domain rare-variant burden study

    S. Parlar, K. Senkevich, E. Yu, J. Ruskey, J. Ahmad, F. Asayesh, D. Spiegelman, C. Waters, O. Monchi, Y. Dauvilliers, N. Dupré, L. Greenbaum, S. Hassin-Baer, I. Miliukhina, A. Timofeeva, A. Emelyanov, S. Pchelina, R. Alcalay, E. Fon, Z. Gan-Or (Montreal, Canada)

    Objective: To study rare variant burden in different LRRK2 domains to investigate domain-based associations with Parkinson’s Disease (PD) and to identify functional variants in LRRK2.…
  • 2024 International Congress

    RAB32 c.213C>G (p.Ser71Arg) explains Parkinson’s disease in two UK families: description of the clinical and biochemical features

    R. Tilney, R. Real, E. Gustavsson, S. Jasaityte, Y. Kordovska, M. Fenn, P. Korlipara, M. Hu, E. Sammler, M. Farrer, H. Morris (London, United Kingdom)

    Objective: To describe the clinical features, family structure of two families identified to have the recently described pathogenic variant RAB32 c.213C>G (p.Ser71Arg). Background: Genetic mutations…
  • 2024 International Congress

    Parkinson’s Families Project: A UK-Wide Study of Early Onset and Familial Parkinson’s Disease

    R. Real, Z-H. Fang, C. Towns, T. Schmaderer, S. Jasaityte, M. Tan, M. Pollard, L. Lange, R. Tilney, A. Singleton, C. Blauwendraat, C. Klein, H. Morris (London, United Kingdom)

    Objective: The Parkinson’s Families Project is a UK-wide study aimed at identifying genetic variation associated with familial and early-onset Parkinson's disease (PD). Background: Rare variants…
  • 2024 International Congress

    Bidirectional Relationship Between Olfaction and Parkinson’s Disease

    J. Kim, S. Bandres-Ciga, K. Heilbron, 23. INC., C. Blauwendraat, A. Noyce (London, United Kingdom)

    Objective: To establish a causal direction and genetic relationship between olfactory function and Parkinson’s disease (PD). Background: Degradation in olfactory function or hyposmia is a…
  • 2024 International Congress

    Clinical Features of dj1 Gene Mutation Causing Parkinson’s Disease from Single Institution

    H. Alhodaif, Y. Alkhodair, A. Aldakheel, S. Alqahtani, S. Boholegah (Riyadh, Saudi Arabia)

    Objective: Describe a detailed clinical and genetic evaluation of patients with Parkinson's disease secondary to DJ1 gene mutation Background: Inherited Parkinson's disease (PD) represents 5-10%…
  • 2024 International Congress

    Oscillatory signatures of genetic Parkinson’s disease patients in subthalamic macroelectrode recordings

    N. Darcy, J. Habets, L. Feldmann, V. Mathiopoulou, JK. Behnke, J. Busch, J. Reimer, P. Krause, M. Gerster, B. Bahners, A. Schnitzler, GH. Schneider, K. Faust, A. Kühn (Berlin, Germany)

    Objective: With electrophysiologically guided adaptive deep brain stimulation (aDBS) fast approaching clinical routine, oscillatory properties in all Parkinson’s disease (PD) patients must be characterised. Genetic…
  • 2024 International Congress

    Clinical applications of cortical finely tuned gamma oscillations induced via subthalamic deep brain stimulation in Parkinson’s disease

    M. Shcherbakova, S. Cernera, A. Hahn, S. Little, P. Starr (San Francisco, USA)

    Objective: To investigate the clinical relevance of entraining finely tuned gamma (FTG) oscillations via deep brain stimulation (DBS) in Parkinson’s disease (PD). Background: Prior studies…
  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley